ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 559

$605K Total Retail Price of All Prescriptions

Rank: 20 out of 559

828 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 828 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 828 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,645 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 761 652 1 2
LISINOPRIL 754 665 2 1
SIMVASTATIN 696 575 3 3
OMEPRAZOLE 502 387 4 4
METFORMIN HCL 430 367 5 5
HYDROCODONE-ACETAMINOPHEN 367 274 S3 6 7
AMLODIPINE BESYLATE 333 292 7 6
LOVASTATIN 320 279 8 10
GABAPENTIN 283 216 9 9
HYDROCHLOROTHIAZIDE 275 236 10 8
METOPROLOL TARTRATE 224 184 11 12
GLYBURIDE 218 168 R 12 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 205 179 13 18
LOSARTAN POTASSIUM 198 191 14 14
PANTOPRAZOLE SODIUM 189 165 15 41
ALENDRONATE SODIUM 181 172 16 13
PROAIR HFA 179 141 17 29
DOXAZOSIN MESYLATE 177 157 18 43
FUROSEMIDE 176 166 19 11
ZOLPIDEM TARTRATE 173 161 20 17
SERTRALINE HCL 172 143 21 19
ADVAIR DISKUS 155 148 22 46
ATENOLOL 152 136 23 15
TAMSULOSIN HCL 151 141 24 25
FELODIPINE ER 147 147 25 72
FENOFIBRATE 123 109 26 69
DONEPEZIL HCL 122 97 27 36
JANUVIA 118 107 28 50
FLUTICASONE PROPIONATE 110 79 29 22
RANITIDINE HCL 107 99 30 26
AZITHROMYCIN 107 82 30 39
OXYBUTYNIN CHLORIDE 100 87 32 62
FLUOXETINE HCL 97 91 33 37
ATORVASTATIN CALCIUM 96 90 34 20
ALLOPURINOL 95 84 35 34
GLIPIZIDE 94 72 36 31
DIOVAN 89 89 37 55
OXYCODONE HCL 88 34 S2 38 32
FINASTERIDE 85 85 39 59
TRAZODONE HCL 83 75 40 28
TRIAMCINOLONE ACETONIDE 75 65 41 84
CRESTOR 75 70 41 33
TRAMADOL HCL 74 55 43 27
LOSARTAN-HYDROCHLOROTHIAZIDE 73 71 44 52
CARVEDILOL 71 61 45 38
TRIAMTERENE-HCTZ 71 71 45 47
METOPROLOL SUCCINATE 70 70 47 16
IBUPROFEN 68 48 48 30
SPIRIVA 66 65 49 67
ESCITALOPRAM OXALATE 66 54 49 109
VENTOLIN HFA 65 63 51 113
PREDNISONE 62 49 52 49
ACETAMINOPHEN-CODEINE 61 57 S3 53 83
CIPROFLOXACIN HCL 60 55 54 60
INSULIN SYRINGE 60 55 54 65
LANTUS 60 56 54 40
CITALOPRAM HBR 60 46 54 21
ENALAPRIL MALEATE 57 57 58 66
CLOPIDOGREL 57 51 58 51
GLIPIZIDE ER 57 51 58 77
POTASSIUM CHLORIDE 57 57 58 23
PAROXETINE HCL 54 54 62 48
SPIRONOLACTONE 52 47 63 74
VERAPAMIL ER 50 50 64 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.